Relebactam
CAS No. 1174018-99-5
Relebactam ( MK-7655 )
产品货号. M10588 CAS No. 1174018-99-5
Relebactam (MK-7655)is a novel β-lactamase inhibitor that inhibited both class A and C β-lactamases in vitro.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥786 | 有现货 |
|
10MG | ¥1256 | 有现货 |
|
25MG | ¥2341 | 有现货 |
|
50MG | ¥4358 | 有现货 |
|
100MG | ¥6302 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Relebactam
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Relebactam (MK-7655)is a novel β-lactamase inhibitor that inhibited both class A and C β-lactamases in vitro.
-
产品描述Relebactam (MK-7655)is a novel β-lactamase inhibitor that inhibited both class A and C β-lactamases in vitro; effectively restored imipenem's activity against imipenem-resistant Pseudomonas and Klebsiella strains at clinically achievable concentrations; reduces imipenem MICs for Enterobacteriaceae with KPC carbapenemases from 16-64 mg/L to 0.12-1 mg/L at a concentration of 4 mg/L.Bacterial Infection Phase 3 Clinical
-
同义词MK-7655
-
通路GPCR/G Protein
-
靶点Antibacterial
-
受体diazabicyclooctane
-
研究领域Infection
-
适应症Bacterial Infection
化学信息
-
CAS Number1174018-99-5
-
分子量348.38
-
分子式C12H20N4O6S
-
纯度>98% (HPLC)
-
溶解度10 mM in DMSO
-
SMILESO=S(O)(ON1[C@]2([H])CC[C@@H](C(NC3CCNCC3)=O)[N@@](C2)C1=O)=O
-
化学全称Sulfuric acid, mono[(1R,2S,5R)-7-oxo-2-[(4-piperidinylamino)carbonyl]-1,6-diazabicyclo[3.2.1]oct-6-yl] ester
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Hirsch EB, et al. Antimicrob Agents Chemother. 2012 Jul;56(7):3753-7.
2. Blizzard TA, et al. Bioorg Med Chem Lett. 2014 Feb 1;24(3):780-5.
3. Livermore DM, et al. J Antimicrob Chemother. 2013 Oct;68(10):2286-90.
2. Blizzard TA, et al. Bioorg Med Chem Lett. 2014 Feb 1;24(3):780-5.
3. Livermore DM, et al. J Antimicrob Chemother. 2013 Oct;68(10):2286-90.
产品手册
关联产品
-
Ceratotoxin B
Ceratotoxins B is antibacterial peptide produced by the sexually mature females of Ceratitis capitata.
-
TCA-1
A small molecule with activity against drug-resistant and persistent tuberculosis; shows bactericidal activity against nonreplicating Mtb in vitro and is efficacious in acute and chronic Mtb infection mouse models.
-
N-Acetyl-D-mannosami...
N-Acetylmannosamine is a drug potentially for the treatment of hereditary inclusion body myopathy.